These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2763 related articles for article (PubMed ID: 23302119)

  • 61. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
    Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
    Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
    Bianchi DW; Platt LD; Goldberg JD; Abuhamad AZ; Sehnert AJ; Rava RP;
    Obstet Gynecol; 2012 May; 119(5):890-901. PubMed ID: 22362253
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Application and evaluation of invasive prenatal diagnostic techniques and analysis of chromosomal karyotype].
    Wang L; Wang X; Zhang S; Zhou Z; Zhu F; Ding Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):400-4. PubMed ID: 23645241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prenatal diagnosis. Review, personal and prospective studies].
    Engel E; Empson J; DeLozier D; McGee B; da Costa Woodson E; Engel-de Montmollin M; Carter T; Lorber C; Cassidy SB; Millis J; Heller RM; Boehm F; Vanhooydonk J
    Schweiz Med Wochenschr; 1979 Jul; 109(27):998-1010. PubMed ID: 88763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Women should decide which conditions matter.
    Norton ME; Kuppermann M
    Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Attitudes of women of childbearing age towards prenatal diagnosis in southeastern France.
    Julian-Reynier C; Macquart-Moulin G; Moatti JP; Loundou A; Aurran Y; Chabal F; Aymé S
    Prenat Diagn; 1993 Jul; 13(7):613-27. PubMed ID: 8415427
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age.
    Su JY; Wei YN; Chen HF; Tong JR; Chen Y; Deng L; Huang LL; Zhang LY
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7101-7106. PubMed ID: 37606120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 72. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Noninvasive prenatal genetic testing in 6804 pregnant women aged less than 35 years with positive results in serum screening].
    Yang X; Guo X; Zhong J; Chen Z; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1350-1356. PubMed ID: 31852638
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience.
    Sago H; Sekizawa A;
    Prenat Diagn; 2015 Apr; 35(4):331-6. PubMed ID: 25408438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Confirmation and analysis of 2 398 positive results of cell-free fetal DNA].
    Zhao JH; Dai P; Zhu RN; Shi PL; Meng JJ; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):679-684. PubMed ID: 33120479
    [No Abstract]   [Full Text] [Related]  

  • 78. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fluorescence in situ hybridization (FISH) for rapid detection of aneuploidy: experience in 911 prenatal cases.
    Weremowicz S; Sandstrom DJ; Morton CC; Niedzwiecki CA; Sandstrom MM; Bieber FR
    Prenat Diagn; 2001 Apr; 21(4):262-9. PubMed ID: 11288114
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 139.